COSCIENS Biopharma Statistics
Total Valuation
CSCI has a market cap or net worth of $7.87 million. The enterprise value is $901,637.
Important Dates
The last earnings date was Thursday, August 14, 2025, after market close.
| Earnings Date | Aug 14, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
CSCI has 3.18 million shares outstanding. The number of shares has increased by 62.42% in one year.
| Current Share Class | 3.18M |
| Shares Outstanding | 3.18M |
| Shares Change (YoY) | +62.42% |
| Shares Change (QoQ) | +0.96% |
| Owned by Insiders (%) | 0.55% |
| Owned by Institutions (%) | 0.84% |
| Float | 2.92M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.83 |
| Forward PS | n/a |
| PB Ratio | 1.11 |
| P/TBV Ratio | 1.11 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 0.10 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.96, with a Debt / Equity ratio of 0.32.
| Current Ratio | 2.96 |
| Quick Ratio | 2.17 |
| Debt / Equity | 0.32 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -75.42 |
Financial Efficiency
Return on equity (ROE) is -113.08% and return on invested capital (ROIC) is -34.66%.
| Return on Equity (ROE) | -113.08% |
| Return on Assets (ROA) | -16.64% |
| Return on Invested Capital (ROIC) | -34.66% |
| Return on Capital Employed (ROCE) | -47.01% |
| Revenue Per Employee | $236,050 |
| Profits Per Employee | -$471,050 |
| Employee Count | 40 |
| Asset Turnover | 0.24 |
| Inventory Turnover | 2.06 |
Taxes
In the past 12 months, CSCI has paid $971,000 in taxes.
| Income Tax | 971,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -39.90% in the last 52 weeks. The beta is 1.98, so CSCI's price volatility has been higher than the market average.
| Beta (5Y) | 1.98 |
| 52-Week Price Change | -39.90% |
| 50-Day Moving Average | 3.50 |
| 200-Day Moving Average | 3.19 |
| Relative Strength Index (RSI) | 37.31 |
| Average Volume (20 Days) | 20,581 |
Short Selling Information
The latest short interest is 9,911, so 0.31% of the outstanding shares have been sold short.
| Short Interest | 9,911 |
| Short Previous Month | 11,117 |
| Short % of Shares Out | 0.31% |
| Short % of Float | 0.34% |
| Short Ratio (days to cover) | 1.67 |
Income Statement
In the last 12 months, CSCI had revenue of $9.44 million and -$18.84 million in losses. Loss per share was -$5.98.
| Revenue | 9.44M |
| Gross Profit | 4.42M |
| Operating Income | -10.33M |
| Pretax Income | -18.05M |
| Net Income | -18.84M |
| EBITDA | -9.19M |
| EBIT | -10.33M |
| Loss Per Share | -$5.98 |
Full Income StatementBalance Sheet
The company has $9.33 million in cash and $2.26 million in debt, giving a net cash position of $7.08 million or $2.23 per share.
| Cash & Cash Equivalents | 9.33M |
| Total Debt | 2.26M |
| Net Cash | 7.08M |
| Net Cash Per Share | $2.23 |
| Equity (Book Value) | 7.10M |
| Book Value Per Share | 2.24 |
| Working Capital | 10.93M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$17.11 million and capital expenditures -$1.10 million, giving a free cash flow of -$18.21 million.
| Operating Cash Flow | -17.11M |
| Capital Expenditures | -1.10M |
| Free Cash Flow | -18.21M |
| FCF Per Share | -$5.73 |
Full Cash Flow StatementMargins
Gross margin is 46.84%, with operating and profit margins of -109.44% and -199.56%.
| Gross Margin | 46.84% |
| Operating Margin | -109.44% |
| Pretax Margin | -189.27% |
| Profit Margin | -199.56% |
| EBITDA Margin | -97.36% |
| EBIT Margin | -109.44% |
| FCF Margin | n/a |
Dividends & Yields
CSCI does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -62.42% |
| Shareholder Yield | -62.42% |
| Earnings Yield | -239.31% |
| FCF Yield | -231.27% |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on May 3, 2024. It was a reverse split with a ratio of 1:4.
| Last Split Date | May 3, 2024 |
| Split Type | Reverse |
| Split Ratio | 1:4 |
Scores
CSCI has an Altman Z-Score of -0.98 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -0.98 |
| Piotroski F-Score | 3 |
